Forest Adding 600 Sales Reps For Memantine, Lercanidipine Launches

Forest is planning to add a 600-rep sales force to support the upcoming launches of the Alzheimer's agent memantineand the anti-hypertensive lercanidipine, President Kenneth Goodman told analysts Oct. 15

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet